Causal effects of chronic kidney diseases, renal function, and dialysis on sarcopenia: Insights from a Mendelian

Clinical Nephrology
|February 27, 2025
PubMed

Insights

This study found that reduced estimated creatinine-based glomerular filtration rate (eGFRcrea) and dialysis are causally linked to sarcopenia, a condition common in chronic kidney disease patients. These findings highlight key factors contributing to muscle loss in kidney disease.

Area of Science:

  • Nephrology
  • Geriatrics
  • Genetics

Background:

  • Sarcopenia is a common complication in patients with chronic kidney disease (CKD), affecting both dialysis and non-dialysis populations.
  • Understanding the causal factors of sarcopenia in CKD is crucial for developing targeted interventions.

Purpose of the Study:

  • To investigate the causal relationships between CKD, renal function (eGFRcrea and eGFRcys), and dialysis status with sarcopenia.
  • To explore the impact of these factors on specific sarcopenia-related traits such as appendicular lean mass and hand grip strength.

Main Methods:

  • Utilized a two-sample Mendelian randomization (MR) approach, employing genetic variants from genome-wide association studies (GWAS).
  • Instrumental variables included CKD, eGFRcrea, eGFRcys, and dialysis status.
  • Sarcopenia traits analyzed were appendicular lean mass (ALM), hand grip strength (HGS), and usual walking pace (UWP).

Main Results:

  • A significant causal effect was observed between decreased eGFRcrea and increased risk of low hand grip strength (HGS) and reduced appendicular lean mass (ALM).
  • Dialysis was also found to be significantly associated with low HGS.
  • No significant causal association was found between eGFRcys or CKD status and sarcopenia.

Conclusions:

  • Declines in estimated creatinine-based glomerular filtration rate (eGFRcrea) and undergoing dialysis are causally associated with sarcopenia.
  • These findings underscore the importance of monitoring renal function and dialysis status in the context of sarcopenia management in CKD patients.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
47
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
667
Kidney Structure01:45

Kidney Structure

The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
68.5K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363